介入栓塞治疗慢性硬膜下血肿的研究进展  

Recent advance in interventional embolization for chronic subdural hematoma

作　　者：王恒禄 王超[1] 李珍珠[1] 徐文虎[1] 李承龙 丁金科 范罡贤 李泽福[1] Wang Henglu;Wang Chao;Li Zhenzhu;Xu Wenhu;Li Chenglong;Ding Jinke;Fan Ganxian;Li Zefu(Department of Neurosurgery,Affiliated Hospital of Binzhou Medical University,Binzhou 256603,China)

机构地区：[1]滨州医学院附属医院神经外科,滨州256603

出　　处：《中华神经医学杂志》2020年第5期528-531,共4页Chinese Journal of Neuromedicine

基　　金：国家自然科学基金(81171119);山东省自然科学基金(ZR2018LH007)。

摘　　要：慢性硬膜下血肿(cSDH)多由头部创伤后数周(≥3周)引起或由积液转化而来。其传统治疗方式以保守治疗和钻孔引流治疗为主,但保守治疗的有效率仅为3%~18%,而钻孔引流治疗的复发率也高达33%。最近基于病理学分析研究提出的脑膜中动脉(MMA)栓塞技术可以大大降低其术后复发率,且操作简单、疗效确切。笔者现对cSDH患者介入栓塞治疗的研究进展进行综述。Chronic subdural hematoma(cSDH)occurs in acute subdural hemorrhage after head trauma or converts from effusion.Traditional treatment is based on conservative treatment and surgical drainage.The effective rate of conservative treatment is only 3%-18%;even with drilling drainage treatment,the recurrence rate is as high as 33%.Recently,the middle meningeal artery embolization technique based on pathological analysis can greatly reduce the recurrence rate,and the operation is simple and curative effect is exact.This article reviews the pathogenesis of cSDH and progress of interventional therapy.

关 键 词：慢性硬膜下血肿 脑膜中动脉 介入栓塞 

分 类 号：R651[医药卫生—外科学]